Howard Shelanski

Davis Polk is advising Murphy USA on its $645 million acquisition of QuickChek Corporation. The transaction is expected to close during the first quarter of 2021, subject to customary…

Davis Polk is advising IHS Markit on its all-stock merger with S&P Global that values IHS Markit at an enterprise value of $44 billion. Under the terms of the merger agreement, each…

Davis Polk achieved a significant victory this week for its client, the New York Stock Exchange (“NYSE”), in a dispute between the three largest U.S. stock-exchange groups and the…

Davis Polk advised The Charles Schwab Corporation on its $26 billion all-stock acquisition of TD Ameritrade Holding Corporation.  Under the agreement, TD Ameritrade stockholders…

Davis Polk advised Dean Foods on antitrust and competition aspects of the sale of substantially all of Dean Foods’ assets and business operations pursuant to Section 363 of the Bankruptcy…

Davis Polk advised our client McKesson, working with four other medical equipment suppliers, in obtaining antitrust clearance to work collaboratively to increase the supply of personal…

Davis Polk is advising Natura Cosméticos S.A. on its all-share acquisition of Avon Products, Inc. The transaction, which is expected to close in early 2020, is subject to customary closing…

Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…

Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…

Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd. (“CR Beer”) to create…